Protective effects of coffee against induction of DNA damage and pre-neoplastic foci by aflatoxin B1

Molecular Nutrition and Food Research

Volumn 58, Issue 2, 2014, Pages 229-238

  Ferk, Franziska ^a   Huber, Wolfgang W ^a   Grasl Kraupp, Bettina ^a   Speer, Karl ^b   Buchmann, Sandra ^b   Bohacek, Rene ^a   Mišík, Miroslav ^a   Edelbauer, Leopold ^c   Knasmüller, Siegfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c Artificial Intelligence   (Austria)

Author keywords

AFB1; Coffee; DNA damage; Pre neoplastic liver foci

Indexed keywords

AFLATOXIN B1; ANTINEOPLASTIC AGENT; GLUCURONOSYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE P1; GSTP1 PROTEIN, RAT;

AFB1; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COFFEE; COMET ASSAY; DNA DAMAGE; DRUG EFFECT; LIVER; LIVER TUMOR; MALE; METABOLISM; PATHOLOGY; PRE-NEOPLASTIC LIVER FOCI; RAT;

AFB1; COFFEE; DNA DAMAGE; PRE-NEOPLASTIC LIVER FOCI;

AFLATOXIN B1; ANIMALS; ANTICARCINOGENIC AGENTS; COFFEE; COMET ASSAY; DNA DAMAGE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE S-TRANSFERASE PI; LIVER; LIVER NEOPLASMS; MALE; RATS;

EID: 84893406435     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300154     Document Type: Article

References (60)

1. Molloy, J. W., Calcagno, C. J., Williams, C. D., Jones, F. J. et al., Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 2012, 55, 429-436.
2. Wild, C. P., Gong, Y. Y., Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis 2010, 31, 71-82.
3. IARC, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, Lyon 1993, pp. 245-395.
4. Wild, C. P., Turner, P. C., The toxicology of aflatoxins as a basis for public health decisions. Mutagenesis 2002, 17, 471-481.
5. Foster, P. L., Eisenstadt, E., Miller, J. H., Base substitution mutations induced by metabolically activated aflatoxin B1. Proc. Natl. Acad. Sci. USA 1983, 80, 2695-2698.
6. Levy, D. D., Groopman, J. D., Lim, S. E., Seidman, M. M. et al., Sequence specificity of aflatoxin B1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. Cancer Res. 1992, 52, 5668-5673.
7. Ayub, M., Sachan, D., Dietary factors affecting aflatoxin Bi carcinogenicity Mal. J. Nutr. 1997, 3, 161-179.
8. Gross-Steinmeyer, K., Stapleton, P. L., Tracy, J. H., Bammler, T. K. et al., Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. Toxicol. Sci., 116, 422-432.
9. Kensler, T. W., Roebuck, B. D., Wogan, G. N., Groopman, J. D., Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol. Sci. 2011, 120(Suppl 1), S28-S48.
10. IARC, Coffee, Tea, Mate, Methylxanthines and Methylglyoxal, International Agency for Research on Cancer, Lyon 1991.
11. Cavin, C., Holzhaeuser, D., Scharf, G., Constable, A. et al., Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem. Toxicol. 2002, 40, 1155-1163.
12. Cavin, C., Marin-Kuan, M., Langouet, S., Bezencon, C. et al., Induction of Nrf2-mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver. Food Chem. Toxicol. 2008, 46, 1239-1248.
13. Ito, Y., Ohnishi, S., Fujie, K., Chromosome aberrations induced by aflatoxin B1 in rat bone marrow cells in vivo and their suppression by green tea. Mutat. Res. 1989, 222, 253-261.
14. Nersesyan, A., Misik, M., Knasmueller, S., in: Knasmueller, S., DeMarini, D. M., Johnson, I., Gerhauser, C. (Eds.), Chemoprevention of Cancer and DNA Damage by Dietary Factors, Wiley-VCH, Weinheim 2009, pp. 211-228.
15. Grasl-Kraupp, B., Luebeck, G., Wagner, A., Low-Baselli, A. et al., Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis). Carcinogenesis 2000, 21, 1411-1421.
16. Pitot, H. C., Altered hepatic foci: their role in murine hepatocarcinogenesis. Annu. Rev. Pharmacol. Toxicol. 1990, 30, 465-500.
17. Bannasch, P., Haertel, T., Su, Q., Significance of hepatic preneoplasia in risk identification and early detection of neoplasia. Toxicol. Pathol. 2003, 31, 134-139.
18. Gopalan, P., Tsuji, K., Lehmann, K., Kimura, M. et al., Modulation of aflatoxin B1-induced glutathione S-transferase placental form positive hepatic foci by pretreatment of rats with phenobarbital and buthionine sulfoximine. Carcinogenesis 1993, 14, 1469-1470.
19. Kimura, M., Lehmann, K., Gopalan-Kriczky, P., Lotlikar, P. D., Effect of diet on aflatoxin B1-DNA binding and aflatoxin B1-induced glutathione S-transferase placental form positive hepatic foci in the rat. Exp. Mol. Med. 2004, 36, 351-357.
20. Ramalakshmi, K., Raghavan, B., Caffeine in coffee: its removal. Why and how? Crit. Rev. Food Sci. Nutr. 1999, 39, 441-456.
21. Gialamas, J., Hoger, H., Adamiker, D., The tumor spectrum of Him:OFA rats. J. Exp. Anim. Sci. 1991, 34, 189-194.
22. Sasaki, Y. F., Kawaguchi, S., Kamaya, A., Ohshita, M. et al., The comet assay with 8 mouse organs: results with 39 currently used food additives. Mutat. Res. 2002, 519, 103-119.
23. Burlinson, B., Tice, R. R., Speit, G., Agurell, E. et al., Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup. Mutat. Res. 2007, 627, 31-35.
24. Grasl-Kraupp, B., Waldhor, T., Huber, W., Schulte-Hermann, R., Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital. Carcinogenesis 1993, 14, 2407-2412.
25. Habig, W. H., Pabst, M. J., Fleischner, G., Gatmaitan, Z. et al., The identity of glutathione S-transferase B with ligandin, a major binding protein of liver. Proc. Natl. Acad. Sci. USA 1974, 71, 3879-3882.
26. Huber, W. W., Prustomersky, S., Delbanco, E., Uhl, M. et al., Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by the coffee components kahweol and cafestol. Arch. Toxicol. 2002, 76, 209-217.
27. Carlberg, I., Mannervik, B., Glutathione reductase. Methods Enzymol. 1985, 113, 484-490.
28. Huber, W. W., Scharf, G., Nagel, G., Prustomersky, S. et al., Coffee and its chemopreventive components Kahweol and Cafestol increase the activity of O6-methylguanine-DNA methyltransferase in rat liver-comparison with phase II xenobiotic metabolism. Mutat. Res. 2003, 522, 57-68.
29. Boyne, A. F., Ellman, G. L., A methodology for analysis of tissue sulfhydryl components. Anal. Biochem. 1972, 46, 639-653.
30. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
31. Dias, R. C., Campanha, F. G., Vieira, L. G., Ferreira, L. P. et al., Evaluation of kahweol and cafestol in coffee tissues and roasted coffee by a new high-performance liquid chromatography methodology. J. Agric. Food Chem. 2010, 58, 88-93.
32. Degen, G. H., Neumann, H. G., The major metabolite of aflatoxin B1 in the rat is a glutathione conjugate. Chem. Biol. Interact. 1978, 22, 239-255.
33. Berges, R., Siess, M. H., Arnault, I., Auger, J. et al., Comparison of the chemopreventive efficacies of garlic powders with different alliin contents against aflatoxin B1 carcinogenicity in rats. Carcinogenesis 2004, 25, 1953-1959.
34. Qin, G., Gopalan-Kriczky, P., Su, J., Ning, Y., Lotlikar, P. D., Inhibition of aflatoxin B1-induced initiation of hepatocarcinogenesis in the rat by green tea. Cancer Lett. 1997, 112, 149-154.
35. Liu, J., Yang, C. F., Wasser, S., Shen, H. M. et al., Protection of Salvia miltiorrhiza against aflatoxin-B1-induced hepatocarcinogenesis in Fischer 344 rats dual mechanisms involved. Life Sci. 2001, 69, 309-326.
36. Huber, W. W., Rossmanith, W., Grusch, M., Haslinger, E. et al., Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver. Food Chem. Toxicol. 2008, 46, 1230-1238.
37. Gross, G., Jaccaud, E., Huggett, A. C., Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem. Toxicol. 1997, 35, 547-554.
38. Kalthoff, S., Ehmer, U., Freiberg, N., Manns, M. P. et al., Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach. Gastroenterology 2010, 139, 1699-1710.
39. Wei, C. I., Hsieh, D. P., Characterization of water-soluble glucuronide and sulphate conjugates of aflatoxin B1. 2. Studies in primary cultures of rat hepatocytes. Food Chem. Toxicol. 1985, 23, 821-825.
40. Wei, C. I., Marshall, M. R., Hsieh, D. P., Characterization of water-soluble glucuronide and sulphate conjugates of aflatoxin B1. 1. Urinary excretion in monkey, rat and mouse. Food Chem. Toxicol. 1985, 23, 809-819.
41. Mykkanen, H., Zhu, H., Salminen, E., Juvonen, R. O. et al., Fecal and urinary excretion of aflatoxin B1 metabolites (AFQ1, AFM1 and AFB-N7-guanine) in young Chinese males. Int. J. Cancer 2005, 115, 879-884.
42. Rohrig, T. P., Yourtee, D. M., In vitro metabolism of aflatoxin Q1 by rat liver post-mitochondrial homogenates. Res. Commun. Chem. Pathol. Pharmacol. 1983, 40, 457-464.
43. Tassaneeyakul, W., Birkett, D. J., McManus, M. E., Veronese, M. E. et al., Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms. Biochem. Pharmacol. 1994, 47, 1767-1776.
44. Gao, S. S., Chen, X. Y., Zhu, R. Z., Choi, B. M. et al., Dual effects of phloretin on aflatoxin B1 metabolism: activation and detoxification of aflatoxin B1. Biofactors 2012, 38, 34-43.
45. Sabisz, M., Skladanowski, A., Modulation of cellular response to anticancer treatment by caffeine: inhibition of cell cycle checkpoints, DNA repair and more. Curr. Pharm. Biotechnol. 2008, 9, 325-336.
46. Boothman, D. A., Schlegel, R., Pardee, A. B., Anticarcinogenic potential of DNA-repair modulators. Mutat. Res. 1988, 202, 393-411.
47. Bedard, L. L., Massey, T. E., Aflatoxin B1-induced DNA damage and its repair. Cancer Lett. 2006, 241, 174-183.
48. Nehlig, A., Debry, G., Potential teratogenic and neurodevelopmental consequences of coffee and caffeine exposure: a review on human and animal data. Neurotoxicol. Teratol. 1994, 16, 531-543.
49. Sanyal, R., Darroudi, F., Parzefall, W., Nagao, M. et al., Inhibition of the genotoxic effects of heterocyclic amines in human derived hepatoma cells by dietary bioantimutagens. Mutagenesis 1997, 12, 297-303.
50. Trosko, J. E., Frank, P., Chu, E. H., Becker, J. E., Caffeine inhibition of postreplication repair of N-acetoxy-2-acetylamino fluorene-damaged DNA in Chinese hamster cells. Cancer Res. 1973, 33, 2444-2449.
51. Kiefer, F., Wiebel, F. J., Caffeine potentiates the formation of micronuclei caused by environmental chemical carcinogens in V79 Chinese hamster cells. Toxicol. Lett. 1998, 96-97, 131-136.
52. Ehrlich, V., Huber, W., Grasl-Kraupp, B., Nersesyan, A. et al., Use of preneoplastic lesions in colon and liver in experimental oncology. Radiol. Oncol. 2004, 38, 205-216.
53. IARC, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, Lyon 2012, pp. 225-248.
54. Wild, C. P., Hasegawa, R., Barraud, L., Chutimataewin, S. et al., Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans. Cancer Epidemiol. Biomarkers Prev. 1996, 5, 179-189.
55. Bravi, F., Bosetti, C., Tavani, A., Bagnardi, V. et al., Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 2007, 46, 430-435.
56. Larsson, S. C., Wolk, A., Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology 2007, 132, 1740-1745.
57. La Vecchia, C., Coffee, liver enzymes, cirrhosis and liver cancer. J. Hepatol. 2005, 42, 444-446.
58. Gelatti, U., Covolo, L., Franceschini, M., Pirali, F. et al., Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J. Hepatol. 2005, 42, 528-534.
59. Hoelzl, C., Knasmuller, S., Wagner, K. H., Elbling, L. et al., Instant coffee with high chlorogenic acid levels protects humans against oxidative damage of macromolecules. Mol. Nutr. Food Res. 2010, 54, 1722-1733.
60. Misik, M., Hoelzl, C., Wagner, K. H., Cavin, C. et al., Impact of paper filtered coffee on oxidative DNA-damage: results of a clinical trial. Mutat. Res. 2010, 692, 42-48.